The adverse impact of cyclosporine on serum lipids in renal transplant recipients. (Q51610594)

8 April 2018

title

The adverse impact of cyclosporine on serum lipids in renal transplant recipients. (English)

1 reference

8 April 2018

0 references

1 reference

Kasiske BL

1

1 reference

8 April 2018

Tortorice KL

2

1 reference

8 April 2018

Heim-Duthoy KL

3

1 reference

8 April 2018

Awni WM

4

1 reference

8 April 2018

Rao KV

5

1 reference

8 April 2018

publication date

1 June 1991

1 reference

8 April 2018

American Journal of Kidney Diseases

published in

1 reference

8 April 2018

volume

17

1 reference

8 April 2018

issue

6

1 reference

8 April 2018

page(s)

700-707

1 reference

8 April 2018

Plasma lipids in kidney transplanted children and adolescents: influence of pubertal development, dietary intake and steroid therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Hyperlipidemia in adult, pediatric and diabetic renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Persistent hyperlipidemia in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Lipid Disorders in Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Effect of alternate-day prednisone on plasma lipids in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Abnormalities in lipoprotein metabolism in Gaucher type 1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

High-density lipoprotein cholesterol is reduced in patients with sarcoidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Characterization of hypocholesterolemia in myeloproliferative disease. Relation to disease manifestations and activity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Increased low-density-lipoprotein catabolism in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Adverse effect of cyclosporin on plasma cholesterol in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Who should be converted from cyclosporine to conventional immunosuppression in kidney transplantation, and why

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Factors contributing for improved graft survival in recipients of kidney transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

The relationship between cyclosporine pharmacokinetic parameters and subsequent acute rejection in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Long-term cyclosporine pharmacokinetic changes in renal transplant recipients: effects of binding and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Effects of cyclosporine therapy on plasma lipoprotein levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Interaction of cyclosporin A with human lipoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Cyclosporine, low-density lipoprotein, and cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

T cells and lymphokines

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Serum cholesterol-lowering activity of granulocyte-macrophage colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Inhibition of lymphoproliferation by hyperlipoproteinemic plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Increased low-density lipoprotein levels after splenectomy: a role for the spleen in cholesterol metabolism in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980355-6

7 January 2021

10.1016/S0272-6386(12)80355-6

Identifiers

DOI

1 reference

8 April 2018

1 reference

8 April 2018